跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 158 条关于
“GemOx”
全部
158
临床试验
128
药物
11
机构
0
资讯
19
3年前
Toripalimab, Lenvatinib, and GEMOX Combination Shows Promise in Advanced Intrahepatic Cholangiocarcinoma
去年
Glofitamab-GemOx Shows Survival Benefit in Phase 3 STARGLO Trial for R/R DLBCL, But FDA Advisory Committee Questions US Applicability
9年前
Atezolizumab, Bevacizumab, and GEMOX Combination Shows Promise in Advanced Biliary Tract Cancer
去年
FDA Accepts sBLA for Glofitamab Plus Chemotherapy in Relapsed/Refractory DLBCL
去年
FDA Advisory Committee Discusses Columvi Combination for Relapsed or Refractory DLBCL
去年
Sintilimab/Chidamide Combination Shows Promising Results in Early-Stage Natural Killer T-Cell Lymphoma
18天前
Subsidised Access to Columvi (Glofitamab) Now Available for Relapsed/Refractory DLBCL Patients in Singapore
9个月前
Miltenyi's Dual-Target CAR-T Therapy Shows Superior Efficacy in Pivotal Trial for Relapsed Large B-Cell Lymphoma
10个月前
NHS Approves Glofitamab for Earlier Treatment of Aggressive Blood Cancer
5个月前
Chugai Receives World-First Approval for Lunsumio-Polivy Combination in Relapsed Large B-Cell Lymphoma
第 1 页,共 2 页
上一页
下一页